¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"prostatic specific antigen"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
specific serum
ƯÀÌÇ÷û
specific soluble substance
ƯÀ̰¡¿ë¹°Áú
stage-specific protein
¹ßÀ°´Ü°èƯÀ̴ܹéÁú
antigen
Ç׿ø
antigen analysis
Ç׿øºÐ¼®
antigen binding capacity
Ç׿ø°áÇÕ´É
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen capture assay
Ç׿øÆ÷È¹ÃøÁ¤
antigen competition
Ç׿ø°æÀï
antigen diffusion constant
Ç׿øÈ®»ê»ó¼ö
antigen excess
Ç׿ø°úÀ×
antigen excess zone
Ç׿ø°úÀ×±¸¿ª
antigen mimicry
Ç׿øÀ¯»ç¼º
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
specific soluble substance
ƯÀ̰¡¿ë¹°Áú
virus-specific
¹ÙÀÌ·¯½ºÆ¯ÀÌ-
antigen
Ç׿ø
accessible antigen
Á¢±Ù°¡´ÉÇ׿ø
antigen competition
Ç׿ø°æÀï
antigen excess
Ç׿ø°úÀ×
antigen mimicry
Ç׿øÀ¯»ç¼º
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
antigen presentation
Ç׿øÀü´Þ
antigen receptor
Ç׿ø¼ö¿ëü
antigen recognition
Ç׿øÀÎÁö
antigen analysis
Ç׿øºÐ¼®
antigen capture assay
Ç׿øÆ÷È¹ÃøÁ¤
antigen binding capacity
Ç׿ø°áÇÕ´É
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
prostatic venous plexus
Àü¸³»ùÁ¤¸Æ¾ó±â
prostatic vesicle
Àü¸³¼±¼Ò¼öÆ÷(îñí¡àÍá³â©øÞ)
ABH antigen
ABH Ç׿ø
B antigen
B Ç׿ø(ù÷ê«)
B cell antigen
B ¼¼Æ÷Ç׿ø
CA 19-9 antigen
CA 19-9 Ç׿ø
CA 50 antigen
CA 50 Ç׿ø
CA-2<
>
CA-2<<ÄÝ·ÎÀ̵åÇ׿ø>>
CD5 antigen
CD5 Ç׿ø
CEA(carcinoembryonic antigen)
žƼº¾ÏÇ׿ø
Cartwright antigen
īƮ¶óÀÌÆ®Ç׿ø
Cha antigen
Cha Ç׿ø
Chido (Ch") antigen
Chido(Ch") Ç׿ø
D antigen
D Ç׿ø
D antigen
DÇ׿ø
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
prostatic sinus
Àü¸³»ùµ¿, Àü¸³¼±µ¿.
prostatic urethra
Àü¸³»ù¿äµµ(¡èñÔ³), Àü¸³¼±¿äµµ.
prostatic urethra
Àü¸³¼±¿äµµ
prostatic urinary sphincter
Àü¸³¼± ¿äµµ°ý¾à±Ù
prostatic utricle
Àü¸³»ù¼Ò½Ç(¡á³ãø) ³²¼ºÀڱà , Àü¸³¼±¼Ò½Ç.
prostatic utricle
Àü¸³»ù¼Ò½Ç
prostatic utricle
Àü¸³»ù¼Ò½Ç(¡á³ãø) ³²¼ºÀÚ?, Àü¸³¼±¼Ò½Ç. ?ÇØºÎ
prostatic utricle
Àü¸³¼±¼Ò½Ç
prostatic venous plexus
Àü¸³»ùÁ¤¸Æ¾ó±â
prostatic vesicle
Àü¸³¼±¼Ò¼öÆ÷(îñí¡àÍá³â©øÞ)
transurethral prostatic resection
°æ¿äµµÀü¸³¼±ÀýÁ¦¼ú(¡îñí¡àÍôîð¶âú).
age specific death rate
¿¬·Éº° »ç¸Á·ü
blood group specific substance
Ç÷¾×ÇüƯÀ̹°Áú.
bulk specific gravity
¿ëÀûºñÁß(é»îÝÝïñì)
donor-specific phage
°ø¿©±ÕƯÀÌÆÄÁö
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½